Phenytoin: Pharmacogenetic polymorphism of 4′-hydroxylation-Reference-Cited by-同舟云学术

Phenytoin: Pharmacogenetic polymorphism of 4′-hydroxylation

Published:1990-01 Issue:3 Volume:46 Page:341-347
ISSN:0163-7258
Container-title:Pharmacology & Therapeutics
language:en
Short-container-title:Pharmacology & Therapeutics

Author:

Inaba T.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference46 articles.

1. The HPPH/phenytoin ratio in urine (phenytoindex) as a parameter for phenytoin requirement predictin in childhood;Albani,1980

2. Inter-ethnic and interphenotype differences among Ghanaians and Caucasians in the metabolic hydroxylation of phenytoin;Andoh;Br. J. clin. Pharmac.,1980

3. Diphenylhydantion half-life in man and its inhibition by phenylbutazone; the role of genetic factors;Andreasen;Acta med. scand.,1973

4. The rate of decline of diphenylhydantoin in human plasma;Arnold;Clin. Pharmac. Ther.,1970

5. Genetic differences in phenytoin pharmacokinetics;Atlas;Devl Pharmac. Ther.,1980

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacogenomics and drug metabolism;Biopharmaceutics and Pharmacokinetics Considerations;2021

2. Phenytoin;The Treatment of Epilepsy;2015-11-17

3. Evaluation of Phenytoin Dosage Regimens Based on Genotyping of CYP2C Subfamily in Routinely Treated Japanese Patients††Financial support: This work was supported in part by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Sciences (JSPS).;Drug Metabolism and Pharmacokinetics;2005

4. Clinical relevance of genetic polymorphisms in the humanCYP2C9gene;European Journal of Clinical Investigation;2003-10-20

5. A Review and Assessment of Potential Sources of Ethnic Differences in Drug Responsiveness;The Journal of Clinical Pharmacology;2003-09